Asif Arif
Division of Nephrology, Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA.
Semin Dial. 2004 Sep-Oct;17(5):398-406. doi: 10.1111/j.0894-0959.2004.17355.x.
Traditionally the placement of a peritoneal dialysis (PD) catheter in a patient with end-stage renal disease (ESRD) has been accomplished by a surgeon and using general anesthesia. This approach often introduces delays in starting PD, incurs additional costs in utilizing an operating room as well as anesthesia services, and introduces the mortality risk associated with general anesthesia. Recent data have emphasized that interventional nephrologists can safely and successfully perform PD access procedures. In this context, operating room facilities and staff and anesthesia services are not required and catheter insertion can be performed in a procedure room using local anesthesia, thereby reducing costs and completely bypassing the mortality risk associated with general anesthesia. When performed by a nephrologist, the catheter insertion can be accomplished swiftly and dialysis therapy initiated in a timely manner. Once begun, the success of PD hinges on reliable and long-term access to the peritoneal cavity. Prospective randomized and nonrandomized studies have shown that PD catheters peritoneoscopically placed by nephrologists have fewer complications (infection, exit site leak) and longer catheter survival rates than those inserted surgically. Although PD offers a variety of advantages, it remains an underutilized form of renal replacement therapy. To counteract PD underutilization, at least two separate centers have demonstrated a positive impact on the growth of the PD population when catheter insertion is performed by nephrologists. This article presents PD access-related procedures currently performed by interventional nephrologists. Furthermore, some of the complicating issues (bowel perforation, catheter migration, prior abdominal surgery) related to PD catheter insertion and management are also discussed.
传统上,终末期肾病(ESRD)患者的腹膜透析(PD)导管置入由外科医生完成,并使用全身麻醉。这种方法往往会导致开始腹膜透析出现延迟,使用手术室以及麻醉服务会产生额外费用,还会带来与全身麻醉相关的死亡风险。最近的数据强调,介入肾脏病医生能够安全且成功地进行腹膜透析通路手术。在这种情况下,不需要手术室设施、工作人员和麻醉服务,导管插入可以在操作室使用局部麻醉进行,从而降低成本并完全规避与全身麻醉相关的死亡风险。由肾脏病医生进行操作时,导管插入可以迅速完成,透析治疗也能及时启动。一旦开始,腹膜透析的成功取决于能否可靠且长期地进入腹膜腔。前瞻性随机和非随机研究表明,与外科手术插入的导管相比,由肾脏病医生通过腹腔镜置入的腹膜透析导管并发症(感染、出口部位渗漏)更少,导管生存率更高。尽管腹膜透析有多种优势,但它仍然是一种未得到充分利用的肾脏替代治疗方式。为了应对腹膜透析利用不足的问题,至少有两个独立的中心表明,当由肾脏病医生进行导管插入时,对腹膜透析患者群体的增长有积极影响。本文介绍了介入肾脏病医生目前进行的与腹膜透析通路相关的手术。此外,还讨论了一些与腹膜透析导管插入和管理相关的复杂问题(肠穿孔、导管移位、既往腹部手术)。